Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy-Reference-Cited by-同舟云学术

Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Published:2014-06 Issue:5 Volume:30 Page:400-405
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Liu Chun-Fu¹²,Chen Lee-Jen³,Tsai Shawn H.³,Lai Chi-Chun²⁴,Chan Wei-Chun³,Wu Wei-Chi²⁴,Wang Nan-Kai²⁴,Chen Kuan-Jen²⁴,Hwang Yih-Shiou²⁴,Chen Yen-Po²⁴,Yeung Ling¹²

Affiliation:

1. Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan.

2. College of Medicine, Chang Gung University, Taoyuan, Taiwan.

3. Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan.

4. Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2013.0169

Reference33 articles.

1. Central serous chorioretinopathy: an update on pathogenesis and treatment

2. Half dose verteporfin PDT for central serous chorioretinopathy

3. CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

4. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy

5. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage;Photodiagnosis and Photodynamic Therapy;2024-10

2. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07

3. No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy;Ophthalmology and Therapy;2023-06-08

4. Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?;Pharmaceuticals;2023-03-27

5. Half-Dose Photodynamic Therapy Recommended in the Management of Central Serous Chorioretinopathy during an Era of Limited Supplies of Verteporfin;Ophthalmologica;2023